Wakactive 200mg Tablet
Product Info
Prescription required | Yes |
Marketer | Vanprom Lifesciences Pvt Ltd |
Active Ingredient | Modafinil (200mg) |
Storage | Store below 30°C |
Chemical Class | Diphenylmethane Derivative |
Habit Forming | ~ |
Therapeutic Class | NEURO CNS |
Action Class | Stimulant/ Drug for excessive sleepiness |
User Rating | 4.3 |
User Reviews | 347 |
FAQ
Wakactive 200mg Tablet Reviews
Wakactive 200mg may also be used to treat obstructive sleep apnea and shift work sleep disorder. Additionally, it has cognitive-enhancing properties and can aid in increased focus, alertness, and productivity.
Wakactive 200mg may be taken with or without food. It is advised to take this medicine at a fixed time each day to maintain a consistent level in the blood. If you miss any doses, take it as soon as you remember. Do not skip any doses and finish the full course of treatment even if you feel better. This medication mustn't be stopped suddenly as it may worsen your symptoms.
Some common side effects of this medicine include headache, nausea, nervousness, anxiety, and insomnia (difficulty sleeping). You may also have diarrhea, indigestion, back pain, and a runny nose. However, these side effects are temporary and usually resolve on their own in some time. Serious side effects are rare but may include skin rashes, severe mood changes, and signs of an allergic reaction. Consult your doctor immediately if you experience any of these side effects.
Always remember that this medicine is only used when advised by a doctor as it is not a replacement for a good sleep routine. You should try to get the right amount of sleep every night. Before taking Wakactive 200mg, inform your doctor if you have any problems with your kidneys, heart, liver, or have a history of seizures (epilepsy or fits). Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or if you have any suicidal thoughts.
How Wakactive 200mg Tablet Works
How to Use Wakactive 200mg Tablet
Benefits of Wakactive 200mg Tablet
- In Narcolepsy (Uncontrollable daytime sleepiness): Narcolepsy is a sleep disorder that causes excessive daytime drowsiness. The affected person may experience excessive sleepiness, sleep paralysis, hallucinations, and in some cases episodes of cataplexy (partial or total loss of muscle control). Wakactive 200mg stimulates the brain and keeps you fully awake and alert. It also relieves these abnormal symptoms and regulates the sleep cycle. This restores normal sleeping habits and improves your quality of life. You will feel more energetic and will be able to perform better in your daily activities. It is also reported to improve cognitive functions, such as enhanced memory, problem-solving abilities, and mental clarity.
Uses of Wakactive 200mg Tablet
- Narcolepsy (Uncontrollable daytime sleepiness)
Wakactive 200mg Tablet Side Effects
Safety Tips
Quick Tips
- Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
- It is not a replacement for a good sleep routine. Try to get the right amount of sleep every night.
- Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
- It may cause addiction/ dependence potential when taken for long term.
- Take it with or without food, preferably in morning time before you need to be alert.
- Do not drive or do anything requiring concentration until you know how it affects you.
- It may cause addiction/ dependence potential when taken for long term.
- Stop taking medication and inform your doctor if you experience rash, itching or breathing problem while taking this medicine.
- Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.
- Do not stop taking the medication suddenly without talking to your doctor.
- Take it with or without food, preferably in morning time before you need to be alert.
- Your doctor may monitor you for heart disease and blood pressure while taking this medicine.
- It is not a replacement for a good sleep routine. Try to get the right amount of sleep every night.
- Stop taking medication and inform your doctor if you experience rash, itching or breathing problem while taking this medicine.
- Do not drive or do anything requiring concentration until you know how it affects you.
- Inform your doctor if you notice difficulty sleeping, diarrhea, hallucinations, nausea, chest pain, and fast or slow heart rate.
- Inform your doctor if you had a history of depression, anxiety, mood disorder, or mania and drug abuse.
- Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.
- It makes contraceptive pills less effective, consult with a doctor for effective contraception.
- It makes contraceptive pills less effective, consult with a doctor for effective contraception.
- Do not stop taking the medication suddenly without talking to your doctor.
- Avoid taking alcohol while taking this medicine as it may lead to increase side effects.
- Avoid taking alcohol while taking this medicine as it may lead to increase side effects.
- It may cause headaches. Drink plenty of water and take a suitable pain killer. Inform your doctor if it does not go away.
- It may cause headaches. Drink plenty of water and take a suitable pain killer. Inform your doctor if it does not go away.
References
- Modafinil. North Wales, PA: Teva Pharmaceuticals USA; 1998 [revised Jan. 2015].
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 933-34.
- Stahl SM, editor. Modafinil. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 453-56.
- Modafinil. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012 [revised 06 Mar. 2017]. (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO).
- Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 141, 145.